EPISODE · Sep 20, 2022 · 11 MIN
Addressing Clinicians’ Challenges and Misinformation Around New and Emerging Treatments for Alzheimer Disease
from Pri-Med Podcasts · host Pri-Med
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/alzheimer-disease-addressing-challenges-pt2 Overview: Alzheimer disease (AD) treatment is evolving. With this rapid expansion in potential therapies, there remain challenges and misconceptions. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions about new and emerging disease-modifying therapies and explores ways in which these treatments may be considered in the future for patients. The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.
What this episode covers
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/alzheimer-disease-addressing-challenges-pt2 Overview: Alzheimer disease (AD) treatment is evolving. With this rapid expansion in potential therapies, there remain challenges and misconceptions. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions about new and emerging disease-modifying therapies and explores ways in which these treatments may be considered in the future for patients. The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.
NOW PLAYING
Addressing Clinicians’ Challenges and Misinformation Around New and Emerging Treatments for Alzheimer Disease
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m